Related references
Note: Only part of the references are listed.Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntingtons disease
Mali Jiang et al.
HUMAN MOLECULAR GENETICS (2013)
Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease
Frank M. Longo et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease
Carmela Giampa et al.
PLOS ONE (2013)
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
CELL STEM CELL (2012)
Optimization of a Small Tropomyosin-Related Kinase B (TrkB) Agonist 7,8-Dihydroxyflavone Active in Mouse Models of Depression
Xia Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity
Carlos F. Ibanez et al.
TRENDS IN NEUROSCIENCES (2012)
Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor
M. Cazorla et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity
Jing Chen et al.
NEUROSCIENCE LETTERS (2011)
Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents
Stephen M. Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
Yuxiang Xie et al.
JOURNAL OF NEUROSCIENCE (2010)
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Sung-Wuk Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
N-acetylserotonin activates TrkB receptor in a circadian rhythm
Sung-Wuk Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Composite Primary Neuronal High-Content Screening Assay for Huntington's Disease Incorporating Non-Cell-Autonomous Interactions
Linda S. Kaltenbach et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity
Sung-Wuk Jang et al.
CHEMISTRY & BIOLOGY (2009)
Appetite Enhancement and Weight Gain by Peripheral Administration of TrkB Agonists in Non-Human Primates
John C. Lin et al.
PLOS ONE (2008)
Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease
Chiara Zuccato et al.
BRAIN PATHOLOGY (2008)
Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration
Andrew D. Strand et al.
JOURNAL OF NEUROSCIENCE (2007)
Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities
Ming D. Qian et al.
JOURNAL OF NEUROSCIENCE (2006)
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
S Ginés et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Overcoming the inhibitors of myelin with a novel neurotrophin strategy
G Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
I Sánchez et al.
NATURE (2003)
Small Molecule Trk Receptor Agonists and Other Neurotrophic Factor Mimetics
Scott J. Pollack et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells
M Encinas et al.
JOURNAL OF NEUROCHEMISTRY (2000)
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
G Ochs et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
Share Paper
